Maplight Therapeutics, INC. (MPLT) — S-1 Filings
All S-1 filings from Maplight Therapeutics, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
MapLight Therapeutics Files S-1 for IPO, Eyes CNS Market with Two Phase 2 Assets
— Sep 19, 2025 Risk: high
MapLight Therapeutics, Inc. (MPLT) is a clinical-stage biopharmaceutical company focused on CNS disorders, filing an S-1 for its initial public offering. The co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX